Q32 Bio Inc. (QTTB)

Q32 Bio Statistics

Total Valuation

Q32 Bio has a market cap or net worth of $52.17 million. The enterprise value is $20.16 million.

Market Cap	52.17M
Enterprise Value	20.16M

Important Dates

The next estimated earnings date is Tuesday, March 10, 2026, before market open.

Earnings Date	Mar 10, 2026
Ex-Dividend Date	n/a

Share Statistics

Q32 Bio has 12.30 million shares outstanding. The number of shares has increased by 92.00% in one year.

Current Share Class	12.30M
Shares Outstanding	12.30M
Shares Change (YoY)	+92.00%
Shares Change (QoQ)	+0.35%
Owned by Insiders (%)	0.66%
Owned by Institutions (%)	15.77%
Float	5.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.57

Current Ratio	4.57
Quick Ratio	4.46
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-29.00

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-33.50%
Return on Invested Capital (ROIC)	-139.52%
Return on Capital Employed (ROCE)	-93.21%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.62M
Employee Count	26
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Q32 Bio has paid $21,000 in taxes.

Income Tax	21,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +26.19% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+26.19%
50-Day Moving Average	3.44
200-Day Moving Average	2.39
Relative Strength Index (RSI)	62.34
Average Volume (20 Days)	176,787

Short Selling Information

The latest short interest is 264,909, so 2.15% of the outstanding shares have been sold short.

Short Interest	264,909
Short Previous Month	282,006
Short % of Shares Out	2.15%
Short % of Float	4.79%
Short Ratio (days to cover)	1.55

Income Statement

Revenue	n/a
Gross Profit	-26.39M
Operating Income	-43.50M
Pretax Income	-42.08M
Net Income	-42.10M
EBITDA	-43.08M
EBIT	-43.50M
Earnings Per Share (EPS)	-$3.45

Balance Sheet

The company has $49.04 million in cash and $17.03 million in debt, with a net cash position of $32.01 million or $2.60 per share.

Cash & Cash Equivalents	49.04M
Total Debt	17.03M
Net Cash	32.01M
Net Cash Per Share	$2.60
Equity (Book Value)	-18.45M
Book Value Per Share	-1.50
Working Capital	39.70M

Cash Flow

In the last 12 months, operating cash flow was -$38.79 million and capital expenditures -$2,000, giving a free cash flow of -$38.79 million.

Operating Cash Flow	-38.79M
Capital Expenditures	-2,000
Free Cash Flow	-38.79M
FCF Per Share	-$3.15

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Q32 Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-92.00%
Shareholder Yield	-92.00%
Earnings Yield	-80.69%
FCF Yield	-74.36%

Analyst Forecast

The average price target for Q32 Bio is $7.33, which is 72.88% higher than the current price. The consensus rating is "Hold".

Price Target	$7.33
Price Target Difference	72.88%
Analyst Consensus	Hold
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2